EGFR and head and neck squamous cell carcinoma: In head and neck squamous cell carcinoma, PS-1 positively modulates epidermal growth factor receptor (EGFR) expression independently of γ-secretase cleavage, whereas downregulation of PS-1 can inhibit the EGFR-STAT pathway [13].